Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Non-Ablative Fractional Laser Complications and Management
Description
The speaker reviews complications of non-ablative fractional laser treatments and how to manage them, emphasizing that while these procedures are generally safe, adverse events are inevitable and clinicians should only perform treatments they understand and can recognize complications from. He highlights that the main risk driver is treatment density rather than depth: higher density increases inflammation, pain, hyperpigmentation, blistering, crusting, and scarring, while lower-density treatments often achieve similar results with fewer side effects and better satisfaction. He discusses temporary expected effects such as erythema, edema, pain, microepidermal debris, and transient hyperpigmentation, as well as more serious issues including herpes outbreaks, hypertrophic scarring from excessive energy or overlap, bacterial infection, and unexpected purpura in fragile, steroid-atrophic skin. He stresses practical prevention strategies like spacing passes, allowing cooling, avoiding over-treating small areas, and using prophylaxis when indicated. For higher-risk patients and pigmentary issues, he recommends very low-density settings and sometimes combining picosecond lasers with fractional laser treatment to reduce post-inflammatory hyperpigmentation. His key management advice is to intervene immediately when problems arise, seek help from colleagues, be honest with the patient, ensure adherence to treatment, and follow them closely, since most complications improve substantially when addressed promptly and appropriately.
View moreConclusions
- Non-ablative fractional lasers are generally very safe when the operator understands fractional resurfacing and basic dermatology, but complications remain inevitable.
- Higher treatment density and excessive overlap or energy increase inflammation, discomfort, hyperpigmentation, and the risk of scarring, so lower-density treatments often achieve similar results with fewer side effects.
- In darker skin types or more pigmented patients, the risk of post-inflammatory hyperpigmentation is higher, making conservative settings and combinations such as picosecond plus low-density fractional treatments preferable.
- Most temporary adverse effects such as erythema, edema, pain, hyperpigmentation, and mild crusting usually resolve with time and appropriate care.
- Serious complications like herpes reactivation, bacterial infection, purpura, hypopigmentation, and hypertrophic scarring can occur, especially with improper timing, inadequate prophylaxis, contamination, or overly aggressive energy delivery.
- When a complication occurs, the best outcome comes from immediate intervention, consultation with colleagues, honesty with the patient, and close follow-up to ensure adherence to the treatment plan.
- Trying to hide or avoid a bad outcome is poor practice and increases both patient harm and medicolegal risk.
- Understanding device physics, skin histology, and patient-specific factors allows clinicians to recognize unusual laser-tissue interactions quickly and adapt treatment safely.
- With prompt recognition and appropriate management, most complications from non-ablative fractional laser treatment can improve substantially or even resolve completely.
- The overall message is that cautious technique, conservative density, and rapid, transparent response to adverse events minimize both complications and liability.
- HR Jalian, CA Jalian, MM Avram Common Causes of Injury and Legal Action in Laser Surgery. JAMA Dermatol 2013; 149(2): 188-93.#10.1001/jamadermatol.2013.1384
- Lim YH, Saberi SA, Kamal K, Jalilian HR, Avram MM. Retrospective Analysis of US Litigations Involving Dermatologists From 2011 to 2022. Dermatol Surg. 2024; 50(6): 518-522.#10.1097/dss.0000000000004142
- Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med. 2009;41(3):185-8.#10.1002/lsm.20755